The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_361	Herpes simplex virus	Seprehvir (HSV1716)	DNA	Herpesviridae	Δγ134.5 attenuated virus mutant	Yes	No	No	ATCC or from the Pediatric Preclinical Testing Program (PPTP)	Human neuroblastoma cell line	CHP-134	4000 cells per well	NA	MTS cell survival assay	0.0001 MOI	100% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26583803
OV_365	Herpes simplex virus	Seprehvir (HSV1716)	DNA	Herpesviridae	Δγ134.5 attenuated virus mutant	Yes	No	No	ATCC or from the Pediatric Preclinical Testing Program (PPTP)	Human neuroblastoma cell line	CHP-134	4000 cells per well	NA	MTS cell survival assay	0.01 MOI	18% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26583803
OV_369	Herpes simplex virus	Seprehvir (HSV1716)	DNA	Herpesviridae	Δγ134.5 attenuated virus mutant	Yes	No	No	ATCC or from the Pediatric Preclinical Testing Program (PPTP)	Human neuroblastoma cell line	CHP-134	4000 cells per well	NA	MTS cell survival assay	0.1 MOI	1% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26583803
OV_373	Herpes simplex virus	Seprehvir (HSV1716)	DNA	Herpesviridae	Δγ134.5 attenuated virus mutant	Yes	No	No	ATCC or from the Pediatric Preclinical Testing Program (PPTP)	Human neuroblastoma cell line	CHP-134	4000 cells per well	NA	MTS cell survival assay	1 MOI	1% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	26583803